We will install a solid target at the 18 MeV medical cyclotron (IBA) of the ETH Hönggerberg including a pneumatic shuttle system and a separate lead-shielded hood. The solid target will enable the production of the longer-lived, radiometal nuclides useful for targeted peptide and protein labeling. We will produce innovative radiopharmaceuticals according to GMP. All clinical researcher within and outside SPHN/PHRT can approach the platform and request innovative radionuclides and radiotracers.